Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND

Author:

Sen Taha1ORCID,Scholtes Rosalie2ORCID,Greasley Peter J.3ORCID,Cherney David Z. I.4ORCID,Dekkers Claire C. J.1ORCID,Vervloet Marc5ORCID,Danser Alexander H. J.6ORCID,Barbour Sean J.7,Karlsson Cecilia8,Hammarstedt Ann8,Li Qiang9,Laverman Gozewijn D.10ORCID,Bjornstad Petter1112ORCID,van Raalte Daniel H.2,Heerspink Hiddo J. L.19ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen Groningen The Netherlands

2. Diabetes Centre, Department of Internal Medicine Amsterdam University Medical Centres, Location VU University Medical Center Amsterdam The Netherlands

3. Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

4. Division of Nephrology, Department of Medicine University Health Network and University of Toronto Toronto Ontario Canada

5. Department of Nephrology and Amsterdam Cardiovascular Sciences Amsterdam University Medical Center Amsterdam The Netherlands

6. Division of Pharmacology and Vascular Medicine, Department of Internal Medicine Erasmus MC Rotterdam The Netherlands

7. Division of Nephrology, Department of Medicine University of British Columbia Vancouver British Columbia Canada

8. Late‐stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

9. The George Institute for Global Health UNSW Sydney Sydney New South Wales Australia

10. Department of Internal Medicine, ZGT Hospital Almelo and Hengelo The Netherlands

11. Department of Pediatrics, Division of Endocrinology University of Colorado School of Medicine Aurora Colorado USA

12. Department of Medicine, Division of Nephrology University of Colorado School of Medicine Aurora Colorado USA

Funder

AstraZeneca

American Heart Association

Boettcher Foundation

Juvenile Diabetes Research Foundation United States of America

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3